Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 4 | |
Outperform | 6 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 9 analysts offering 12 month price targets for Krystal Biotech Inc have a median target of 206.00, with a high estimate of 221.00 and a low estimate of 193.00. The median estimate represents a 11.67% increase from the last price of 184.48.
High | 19.8% | 221.00 |
Med | 11.7% | 206.00 |
Low | 4.6% | 193.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 04, 2024.
Average growth rate | +495.81% |
Average growth rate | -66.98% |
More ▼
Revenue history & estimates in USD
Average growth rate | +151.75% |
Average growth rate | 0.00% |
More ▼